CDK2AP1 and cancer: Therefore, we established 2 categories of CDK2AP1 immunoreactivity based on the staining intensity, and an optimal threshold of 35% cancer cells negative for CDK2AP1 was found (P = .024; see Methods and Figure S3, A).